Larvol Delta - Clinical-Study-of-VG161-in-Combination-With-Nivolumab-in-Subjects-With-Advanced-Pancreatic-Cancer

Opdivo (nivolumab) - Ono Pharma, BMS

VG161 - ViroGin Biotech

http://clinicaltrials.gov/ct2/show/NCT05162118

Mar 9, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next